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A commentary on
Commentary: Morphologically Distinct Escherichia coliBacteriophages Differ in Their Efficacy
and Ability to Stimulate Cytokine Release In Vitro
by Dufour, N., Henry, M., Ricard, J.-D., and Debarbieux, L. (2016). Front. Microbiol. 7:1029. doi:
10.3389/fmicb.2016.01029
In their recent commentary on our manuscript entitled “Morphologically Distinct Escherichia coli
Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In vitro,” Dufour
et al. suggest that the level of cytokine response generated in our paper is due to remaining bacterial
debris rather than true differences between individual phages (Dufour et al., 2016).
Although at their core the two preparative methods are similar (both require filtration,
CsCl centrifugation and dialysis). The additional purification step (the EndoTrap Blue system)
binds endotoxins based on the conserved core of lipopolysaccharide (http://www.hyglos.de/en/
products-services/products/endotoxin-removal/faq.html), which to our understanding is achieved
through lipopolysaccharide specific binding to a phage derived protein. However, as Dufour
et al. rightly point out, “bacterial lysates may also contain several pathogen-associated molecular
patterns (PAMPs) able to elicit a pro-inflammatory response, such as flagellin (sensed by TLR-5),
unmethylated CpG Oligodeoxynucleotide DNA (TLR-9), lipoteichoic acid from Gram-positive
bacteria (TLR-2) and triacyl lipopeptides (TLR-1 with TLR-2) (Akira and Hemmi, 2003).” While
such additional debris components may initially be in the minority of remaining debris, they
would not be removed by the Endotrap system and may not be quantified as part of a Limulus
amebocyte lystate (LAL) assay. Indeed, there have been previous instances where LAL assessment
of phage preparations required alternative quantification methods (Merabishvili et al., 2009) or
produced non-comparative results to an ELISA based system (Szermer-Olearnik and Boratyn´ski,
2015). Therefore, had a true comparative analysis between the preparative methods and the same
bacterial species been performed, differences could potentially have been less. However, to our
knowledge no such studies have been performed.
With hindsight and a thorough data audit, we would certainly concur that at least some
component of the observed cytokine responses are due to remaining contaminants and
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that additional purification steps such as chromatography
will further reduce possible contaminants. However, such
additional steps could come at a cost, reduce overall phage
concentration and potentially require additional concentration
steps (Boratyn´ski et al., 2004). As such we would suggest
appropriate caution when interpreting our data and would
highlight that the other data presented in the paper are
consistent with the position that phages are not directly cytotoxic
(Merabishvili et al., 2009; Chhibber et al., 2014; Henein et al.,
2016).
However, while it is likely that some component of
the cytokine response generated is due to remaining
contaminants, additional variation could also be introduced
through factors which are uncontrollable, such as genetic
variation in Toll receptors between different donors
(Netea et al., 2012).
Despite the suggestion to the contrary provided by the
Dufour et al. commentary, the reduction and quantification
of endotoxin in phage preparations remains an active area of
research (Branston et al., 2015; Szermer-Olearnik and Boratyn´ski,
2015) as more effective, less labor intensive, and perhaps most
importantly for commercial development, more cost effective
methods are sought. However, this highlights the disparity
between preparative methods for phage assessment and once
again shows the urgent need for standardized methods and
acceptance criteria, similar to those employed in antibiotic and
biocide development to be developed.
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